EUVIMEDEUVIMED entdecken
Crossref

Multilevel Social Determinant Assessments of Skull-Base Squamous Cell Carcinoma Treatment Disparities in the United States

Jill N. D'Souza, Daniel C. Chelius, Jeffrey C. Rastatter, Anthony M. Sheyn

Journal of Neurological Surgery Part B: Skull Base · 28.04.2026

DOI: 10.1055/a-2853-7730 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 28.04.2026. Verfasst von Jill N. D'Souza und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Utilizing a national patient population of skull-base squamous cell carcinoma patients (SBSC) and multilevel social determinants of health (SDoH) models comprising individual- and community-level factors, including the Yost-SES-Index, to observe how multilevel social determinant factors associate with SBSC treatment disparities across the United States. Design, Setting, Participants Retrospective cohort study assessed SBSC patients between 2010 and 2018 from SEER, and these patients were analyzed by age-adjusted multivariable, multilevel logistic regression models utilizing covariates of individual-level sex and race/ethnicity and census-level rurality–urbanicity and Yost-socioeconomic status (SES)-Index (composite measure of poverty, education, income, housing) were logistically regressed, stratified across non-/nasopharyngeal-SBSC types. Main Outcome Measures Surgical treatment, radiation therapy, chemotherapy, and delay-in-treatment-initiation (3-or-more months after diagnosis) outcomes Results Across 8,852 patients, lower Yost-SES-Index (odds ratio: 0.73, 95% confidence interval: 0.63–0.85) was a negative predictor of non-nasopharyngeal-SBSC-surgery. For radiation therapy receipt, female sex (1.33, 1.16–1.54) was a non-nasopharyngeal SBSC-positive predictor, whereas lower Yost-SES-Index (0.75, 0.64–0.87) was a nasopharyngeal-SBSC negative predictor. For chemotherapy, minority race/ethnicity was a non-nasopharyngeal-SBSC positive predictor (1.25, 1.07–1.46), whereas lower Yost-SES-Index (0.85, 0.73–0.98) was a nasopharyngeal-SBSC-negative predictor. Finally, female sex (1.40, 1.17–1.69), minority race/ethnicity (1.30, 1.08–1.57), and lower Yost-SES-Index (1.49, 1.24–1.79) were markedly positive predictors for delays-in-treatment.

Conclusion

For SBSC, minority race/ethnicity, female sex, and community-level SES were the greatest independent factor associated with treatment disparities. Rurality–urbanicity was not significantly associated with treatment disparities. Multilevel modeling objectively assessed the associative effects of each factor for conferring treatment disparities.

Zitieren

APA

D'Souza, J. N., Chelius, D. C., Rastatter, J. C., & Sheyn, A. M. (2026). Multilevel Social Determinant Assessments of Skull-Base Squamous Cell Carcinoma Treatment Disparities in the United States. Journal of Neurological Surgery Part B: Skull Base. https://doi.org/10.1055/a-2853-7730

Vancouver

D'Souza JN, Chelius DC, Rastatter JC, Sheyn AM. Multilevel Social Determinant Assessments of Skull-Base Squamous Cell Carcinoma Treatment Disparities in the United States. Journal of Neurological Surgery Part B: Skull Base. 2026. doi:10.1055/a-2853-7730

BibTeX
@article{DSouza2026,
  author = {D'Souza, Jill N. and Chelius, Daniel C. and Rastatter, Jeffrey C. and Sheyn, Anthony M.},
  title = {Multilevel Social Determinant Assessments of Skull-Base Squamous Cell Carcinoma Treatment Disparities in the United States},
  journal = {Journal of Neurological Surgery Part B: Skull Base},
  year = {2026},
  doi = {10.1055/a-2853-7730}
}
Kostenlos starten →